ES546655A0 - Metodo de produccion de una proteina con actividad procoagu-lante del tipo de factor viii:c humano - Google Patents

Metodo de produccion de una proteina con actividad procoagu-lante del tipo de factor viii:c humano

Info

Publication number
ES546655A0
ES546655A0 ES546655A ES546655A ES546655A0 ES 546655 A0 ES546655 A0 ES 546655A0 ES 546655 A ES546655 A ES 546655A ES 546655 A ES546655 A ES 546655A ES 546655 A0 ES546655 A0 ES 546655A0
Authority
ES
Spain
Prior art keywords
procoagu
lante
protein
activity
production method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES546655A
Other languages
English (en)
Other versions
ES8704546A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetics Institute LLC
Original Assignee
Genetics Institute LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27068312&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES546655(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/546,650 external-priority patent/US4757006A/en
Application filed by Genetics Institute LLC filed Critical Genetics Institute LLC
Publication of ES8704546A1 publication Critical patent/ES8704546A1/es
Publication of ES546655A0 publication Critical patent/ES546655A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES546655A 1983-10-28 1985-09-02 Metodo de produccion de una proteina con actividad procoagu-lante del tipo de factor viii:c humano Expired ES8704546A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/546,650 US4757006A (en) 1983-10-28 1983-10-28 Human factor VIII:C gene and recombinant methods for production
US64403684A 1984-08-24 1984-08-24

Publications (2)

Publication Number Publication Date
ES8704546A1 ES8704546A1 (es) 1987-04-01
ES546655A0 true ES546655A0 (es) 1987-04-01

Family

ID=27068312

Family Applications (4)

Application Number Title Priority Date Filing Date
ES537146A Expired ES8700868A1 (es) 1983-10-28 1984-10-26 Metodo de aislamiento de un fragmento de gen que codifica por lo menos una porcion de una proteina.
ES546653A Expired ES8800987A1 (es) 1983-10-28 1985-09-02 Metodo de produccion del factor viii:c humano
ES546654A Expired ES8800359A1 (es) 1983-10-28 1985-09-02 Metodo de produccion de factor viii:c humano
ES546655A Expired ES8704546A1 (es) 1983-10-28 1985-09-02 Metodo de produccion de una proteina con actividad procoagu-lante del tipo de factor viii:c humano

Family Applications Before (3)

Application Number Title Priority Date Filing Date
ES537146A Expired ES8700868A1 (es) 1983-10-28 1984-10-26 Metodo de aislamiento de un fragmento de gen que codifica por lo menos una porcion de una proteina.
ES546653A Expired ES8800987A1 (es) 1983-10-28 1985-09-02 Metodo de produccion del factor viii:c humano
ES546654A Expired ES8800359A1 (es) 1983-10-28 1985-09-02 Metodo de produccion de factor viii:c humano

Country Status (9)

Country Link
EP (1) EP0162067B1 (es)
JP (4) JPH07106156B2 (es)
DK (1) DK174927B1 (es)
ES (4) ES8700868A1 (es)
FI (1) FI86436C (es)
IE (1) IE57884B1 (es)
IT (1) IT1177066B (es)
MX (1) MX9203437A (es)
WO (1) WO1985001961A1 (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210501A (en) * 1983-12-13 1991-08-27 Kirin Amgen Inc Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
US4703008A (en) * 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
KR850004274A (ko) * 1983-12-13 1985-07-11 원본미기재 에리트로포이에틴의 제조방법
US4716117A (en) * 1984-10-26 1987-12-29 Chiron Corporation Monoclonal antibodies to factor VIIIC
US5004804A (en) * 1984-01-12 1991-04-02 Nordisk Gentofte Method and composition for preparation of factor VIIIC
DE10399011I1 (de) * 1984-01-12 2003-10-23 Chiron Corp F}r Fakton-VIIIc kodierende DNA-Sequenzen und ver wandte DNA-Konstruktionen
US5045455A (en) * 1984-01-12 1991-09-03 Chiron Corporation Factor VIII:C cDNA cloning and expression
ZA852099B (en) * 1984-03-26 1985-12-24 Meloy Lab Recombinant factor viii-c.
IL74909A (en) * 1984-04-20 1992-01-15 Genentech Inc Preparation of functional human factor viii and dna sequences,expression vectors,transformed microorganisms and cell lines used therein
US4965199A (en) * 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
EP0182448A3 (en) * 1984-08-24 1987-10-28 Genetics Institute, Inc. Production of factor viii and related products
JPS62502589A (ja) * 1985-04-11 1987-10-08 ザ・チヤイルドレンズ・メデイカル・センタ−・コ−ポレ−シヨン フオン・ビルブラント因子
US8597910B1 (en) 1985-04-11 2013-12-03 Children's Medical Center Corporation DNA encoding Von Willebrand Factor (VWF) and methods and cells for producing VFW, and VFW produced by the DNA, methods and cells
DE3531360A1 (de) * 1985-09-03 1987-05-07 Merck Patent Gmbh Dna-sequenzen, rekombinante dna-molekuele und verfahren zur herstellung des enzyms mutarotase aus acinetobacter calcoaceticus
US5250421A (en) * 1986-01-03 1993-10-05 Genetics Institute, Inc. Method for producing factor VIII:C-type proteins
DE3785102T2 (de) * 1986-01-03 1993-07-22 Genetics Inst Verfahren zur herstellung von faktor-viii:c-typ-proteinen.
US5198349A (en) * 1986-01-03 1993-03-30 Genetics Institute, Inc. Method for producing factor VIII:C and analogs
US5595886A (en) * 1986-01-27 1997-01-21 Chiron Corporation Protein complexes having Factor VIII:C activity and production thereof
FR2599754B1 (fr) * 1986-06-06 1989-12-29 Transgene Sa Procede de preparation de facteur viii a partir de cellules de mammiferes
EP0254076B1 (en) 1986-07-11 1991-05-08 Miles Inc. Improved recombinant protein production
JP2872255B2 (ja) * 1987-01-30 1999-03-17 バイオジエン，インコーポレイティド ファクター▲ｖｉｉｉ▼の高収量生産法
CA1331157C (en) * 1987-04-06 1994-08-02 Randal J. Kaufman Method for producing factor viii:c-type proteins
US6060447A (en) * 1987-05-19 2000-05-09 Chiron Corporation Protein complexes having Factor VIII:C activity and production thereof
EP0294910B1 (en) 1987-06-12 1996-09-11 Immuno Ag Novel proteins with factor VIII activity, process for their preparation using genetically engineered cells and pharmaceutical compositions containing them
EP0500734B1 (en) * 1989-11-17 1998-02-11 Novo Nordisk A/S Protein complexes having factor viii:c activity and production thereof
US5155218A (en) 1990-05-08 1992-10-13 Neurogenetic Corporation Dna encoding human 5-ht1d receptors
DK53792D0 (da) * 1992-04-24 1992-04-24 Novo Nordisk As Fremgangsmaade til fremstilling af proteiner
US5563045A (en) * 1992-11-13 1996-10-08 Genetics Institute, Inc. Chimeric procoagulant proteins
US5910481A (en) * 1995-11-13 1999-06-08 Immuno Ag Hybrid proteins with modified activity
US6221349B1 (en) 1998-10-20 2001-04-24 Avigen, Inc. Adeno-associated vectors for expression of factor VIII by target cells
US6200560B1 (en) 1998-10-20 2001-03-13 Avigen, Inc. Adeno-associated virus vectors for expression of factor VIII by target cells
JP5054975B2 (ja) 2003-09-30 2012-10-24 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア アデノ随伴ウイルス（ａａｖ）の同源系統群、配列、それらを含有するベクターおよびそれらの用途
WO2005123928A1 (en) * 2004-06-08 2005-12-29 Battelle Memorial Institute Production of human coagulation factor viii from plant cells and whole plants
JP5702519B2 (ja) 2005-04-07 2015-04-15 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア Ａａｖベクターの機能を上げる方法
US20130023033A1 (en) 2010-03-29 2013-01-24 The Trustees Of The University Of Pennsylvania Pharmacologically induced transgene ablation system
US9315825B2 (en) 2010-03-29 2016-04-19 The Trustees Of The University Of Pennsylvania Pharmacologically induced transgene ablation system
ES2724800T3 (es) 2011-02-17 2019-09-16 Univ Pennsylvania Composiciones y métodos para alterar la especificidad de tejido y mejorar la transferencia génica mediada por AAV9
US9719106B2 (en) 2013-04-29 2017-08-01 The Trustees Of The University Of Pennsylvania Tissue preferential codon modified expression cassettes, vectors containing same, and uses thereof
ES2763551T3 (es) 2015-04-16 2020-05-29 Univ Emory Promotores y vectores recombinantes para la expresión de proteínas en el hígado y uso de los mismos
US20240043494A1 (en) 2020-08-07 2024-02-08 Amicus Therapeutics, Inc. Vesicle Targeting Proteins And Uses Of Same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US602312A (en) * 1898-04-12 eades
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4663280A (en) * 1983-05-19 1987-05-05 Public Health Research Institute Of The City Of New York Expression and secretion vectors and method of constructing vectors
IE81141B1 (en) * 1983-06-24 2000-04-05 Genencor Int Procaryotic carbonyl hydrolases
DE10399011I1 (de) * 1984-01-12 2003-10-23 Chiron Corp F}r Fakton-VIIIc kodierende DNA-Sequenzen und ver wandte DNA-Konstruktionen
ZA852099B (en) * 1984-03-26 1985-12-24 Meloy Lab Recombinant factor viii-c.
IL74909A (en) * 1984-04-20 1992-01-15 Genentech Inc Preparation of functional human factor viii and dna sequences,expression vectors,transformed microorganisms and cell lines used therein

Also Published As

Publication number Publication date
ES8704546A1 (es) 1987-04-01
MX9203437A (es) 1992-07-01
ES537146A0 (es) 1986-10-16
IE57884B1 (en) 1993-05-05
FI86436C (fi) 1992-08-25
JPS61500646A (ja) 1986-04-10
ES8800359A1 (es) 1987-10-16
ES546654A0 (es) 1987-10-16
JP2549049B2 (ja) 1996-10-30
EP0162067A1 (en) 1985-11-27
EP0162067B1 (en) 1992-07-15
EP0162067A4 (en) 1988-03-22
IT8423351A0 (it) 1984-10-26
DK292385A (da) 1985-06-27
IT1177066B (it) 1987-08-26
JPH0690763A (ja) 1994-04-05
JPH07106156B2 (ja) 1995-11-15
DK292385D0 (da) 1985-06-27
JPH02182188A (ja) 1990-07-16
WO1985001961A1 (en) 1985-05-09
FI86436B (fi) 1992-05-15
FI852547L (fi) 1985-06-27
ES546653A0 (es) 1987-12-16
JPH02227078A (ja) 1990-09-10
DK174927B1 (da) 2004-03-01
ES8800987A1 (es) 1987-12-16
ES8700868A1 (es) 1986-10-16
FI852547A0 (fi) 1985-06-27

Similar Documents

Publication Publication Date Title
ES546655A0 (es) Metodo de produccion de una proteina con actividad procoagu-lante del tipo de factor viii:c humano
DK203187A (da) Human g-csf proteinekspression
IT8453746V0 (it) Spazzolino per denti
IT1134586B (it) Spazzolino da denti con testina porta-setole argentata
BR8405574A (pt) Figura de brinquedo acionavel
DK500784D0 (da) Biomedicinsk elektrode
DE3476823D1 (de) Polarity-reversable electrode
FR2556961B1 (fr) Dentifrice
DK336184D0 (da) Medikamentapplikator
KR850002629A (ko) 전극헤드
IT1178858B (it) Procedimento per la produzione di triptofano
IT1177519B (it) Spazzolino da denti
FR2544989B1 (fr) Stimulateur cardiaque auriculo-ventriculaire
DK419486D0 (da) Proteinekspression
AT382075B (de) Hautpflegemittel
FR2544988B1 (fr) Stimulateur cardiaque auriculo-ventriculaire
DK110683D0 (da) Boersteaggregat
KR880004031U (ko) 부러시체를 교환할수 있는 치솔
ES499160A0 (es) Un procedimiento para la produccion de una proteina con propiedades similares a las del interferon humano.
IT8320239A0 (it) Derivato del tetraidrotiofenone attivo nelle affezioni broncopolmonari.
AR220640A1 (es) Cepillo dental masajeador
IT8351505V0 (it) Spazzolino da denti
KR840005116U (ko) 1회용 샴푸
IT8511314V0 (it) Spazzolino dentale doppio conico
IT8604724V0 (it) Spezzolini da denti con setole sostituibili

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20040916